Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04166539 · ClinicalTrials.gov registry record
Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 115
- Enrollment target
NCT04166539: Completed study, sponsored by Mayo Clinic.
NCT04166539 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 115 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04166539 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 115 participants
- Enrollment target
Study Summary
The purpose of this research is to understand whether patients who previously had total hip or total knee replacement experience memory, thinking or heart problems. This study will help us determine if and how often these problems occur.
Primary Outcome
Cognitive impairment as assessed through interviews
Interventions
- OTHER Blood draw
- BEHAVIORAL Questionnaires
- DIAGNOSTIC_TEST Echocardiogram
- BEHAVIORAL Interviews
- RADIATION Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2021-09-27 |
What the finished NCT04166539 record still lists
NCT04166539 is an observational study that tracks outcomes without assigning an intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Blood draw is the first listed.
NCT04166539 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04166539 about?
NCT04166539 is a clinical study titled "Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty". The purpose of this research is to understand whether patients who previously had total hip or total knee replacement experience memory, thinking or heart problems. This study will help us determine if and how often these problems occur.
What is the current status of trial NCT04166539?
This trial is currently completed. The enrollment target is 115 participants. The study started on 2019-10-01. Estimated completion is 2021-09-27.
What interventions are being tested in trial NCT04166539?
The interventions under investigation include: Blood draw (OTHER), Questionnaires (BEHAVIORAL), Echocardiogram (DIAGNOSTIC_TEST), Interviews (BEHAVIORAL), Magnetic Resonance Imaging (RADIATION).
Who is sponsoring clinical trial NCT04166539?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI